The same results were observed in other cancers: The down-regulation of ANXA2 in lung cancer cell line A54918 or breast cancer cell line MDA-MB-23119 significantly reduced the proliferation capacity of tumor cells. This evidence concerns the gene ANXA2 and lung carcinoma.